Publications by authors named "Helmut Schrott"

Claim this Profile
T
The interaction of familial and secondary causes of hypertriglyceridemia: role in pancreatitis.
John D Brunzell, Helmut G Schrott

J Clin Lipidol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin pleiotropy: a popular concept but clinical significance unclear.
Jennifer G Robinson, Helmut Schrott

Cardiovasc Drugs Ther· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis.
Jennifer G Robinson, Brian Smith, Nidhi Maheshwari, Helmut Schrott

J Am Coll Cardiol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals.
Theodore Feldman, Michael Koren, William Insull, James McKenney, Helmut Schrott

Am J Cardiol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of extended-release niacin with lovastatin for hypercholesterolemia: assessing all reasonable doses with innovative surface graph analysis.
William Insull, Mark E McGovern, Helmut Schrott, Paul Thompson, J Robin Crouse

Arch Intern Med· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol.
Harold E Bays, James M McKenney, Carlos A Dujovne, Helmut G Schrott, Michael J Zema

Am J Cardiol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia.
Jonathan Isaacsohn, Donald Hunninghake, Helmut Schrott, Carlos A Dujovne, Robert Knopp

Clin Cardiol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
Stephen Hulley, Curt Furberg, Elizabeth Barrett-Connor, Jane Cauley, Deborah Grady, Helmut Schrott

JAMA· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS).
David M Herrington, Eric Vittinghoff, Feng Lin, Josephine Fong, Fran Harris, Helmut G Schrott

Circulation· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis